Upon completion of the certification exercise, the HRT began to expand its capabilities by sending small teams of operators out for more specialized training courses.
Current users of estrogen-progestogen HRT were at 2 fold increased risk of developing breast cancer, and current users of estrogen-only HRT at 1.3 fold risk.